NRx Pharmaceuticals Stock Rises 33% on Psychiatry Clinic Acquisition
NRx Pharmaceuticals shares gained after the company said it would buy California psychiatry clinic Kadima Neuropsychiatry Institute. The stock rose Thursday to $2.92, reaching a six-month high. Shares ...
1 Beaten-Down Stock That Could Soar by 50% in 2025, According to Wall Street
Biotech giant Regeneron Pharmaceuticals (NASDAQ: REGN) started 2024 on a strong note and performed well through the first half of the year. Regeneron's stock could soar by 50% in the next year from ...